" class="no-js "lang="en-US"> Industry News Archives - Page 133 of 151 - Medtech Alert
Sunday, October 19, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing to Canada

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]

Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the […]

BioLife Solutions to Acquire Sexton Biotechnologies to Expand Cell and Gene Therapy Tools Portfolio

BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products […]

The Biotech Market: Why Investors Should Take Interest

As the biotech industry continues to reach new heights, Maxim Manturov, Head of Investment Research at Freedom Finance […]

Aardvark Therapeutics, Inc., Completes $29m Series B Funding Led by Sorrento Therapeutics and Including Existing Investors and the Foundation for Prader-Willi Research

Aardvark Therapeutics, Inc., a clinical stage biopharmaceutical company focused on developing and commercializing novel small […]

World-renowned Urologist Professor Prokar Dasgupta Joins MysteryVibe as Chief Medical Officer

MysteryVibe announces the strategic hire of Professor Prokar Dasgupta as their new Chief Medical Officer (CMO), to support the development […]

Healx Launches AI-powered Indication Expansion Partnership with Ono Pharmaceutical Co. Ltd.

Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, today announced […]

Medtronic to Acquire Intersect ENT

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has entered […]

Heru, the Wearable Diagnostic and Vision Augmentation Leader, Launches Commercial Availability of re:Vive in Partnership with Vision Source

Heru Inc., the innovator of the vision diagnostics and augmentation platform, announced in partnership with […]

Telstra Health and Hayylo Partner to Streamline Aged Care and Disability Client Interactions

Telstra Health has partnered with Hayylo, a homegrown award winning software platform, to simplify digital […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more